Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Investigational New Drugs|April 9, 2001
Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology GroupB J Giantonio, H Hochster, R Blum, et al.American Journal of Epidemiology|October 1, 1988
Investigation of an outbreak of Salmonella enteritidis gastroenteritis associated with consumption of eggs in a restaurant chain in MarylandF Y Lin, J G Morris, D Trump, et al.Journal of Medical Genetics|June 7, 2005
X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patientsD Pimenides, N D L George, J R W Yates, et al.Analytical Biochemistry|January 15, 1999
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylationC A O'callaghan, M F Byford, J R Wyer, et al.European Journal of Immunology|June 1, 1997
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopesP J Goulder, S W Reid, D A Price, et al.Genomics|November 5, 1997
High-resolution physical map of the X-linked retinoschisis interval in Xp22S M Walpole, A Nicolaou, G R Howell, et al.Genomics|August 29, 1998
Identification and characterization of a novel serine-threonine kinase gene from the Xp22 regionE Montini, G Andolfi, A Caruso, et al.Human Molecular Genetics|August 1, 2000
Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cellsC Grayson, S N Reid, J A Ellis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyS B Saxman, K J Propert, L H Einhorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 studyP W Kantoff, S Halabi, M Conaway, et al.Pageof 12